Madrigal Pharmaceuticals Inc
(MDGL)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -31,994 | -23,499 | -92,618 | -66,665 | -40,344 |
| Depreciation Amortization | 1,344 | 693 | 2,717 | 2,035 | 1,306 |
| Accounts receivable | 15,093 | 16,000 | N/A | N/A | -257 |
| Accounts payable and accrued liabilities | 6,330 | 9,535 | 7,134 | 3,339 | 1,200 |
| Other Working Capital | 17,143 | 33,867 | 44,390 | 4,323 | 483 |
| Other Operating Activity | -19,211 | -24,370 | 438 | 2,477 | 2,951 |
| Operating Cash Flow | $-11,295 | $12,226 | $-37,939 | $-54,491 | $-34,661 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -7,143 | -22,084 | -21,503 | N/A | N/A |
| PPE Investments | -483 | -382 | -2,184 | -1,435 | -991 |
| Investing Cash Flow | $-7,626 | $-22,466 | $-23,687 | $-1,435 | $-991 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1,241 | -650 | -2,787 | -2,134 | -1,429 |
| Common Stock Issued | N/A | N/A | 1 | 1 | N/A |
| Other Financing Activity | 0 | 0 | 880 | 880 | 880 |
| Financing Cash Flow | $-1,241 | $-650 | $-1,906 | $-1,253 | $-549 |
| Beginning Cash Position | 52,045 | 52,045 | 115,577 | 115,577 | 115,577 |
| End Cash Position | 31,883 | 41,155 | 52,045 | 58,398 | 79,376 |
| Net Cash Flow | $-20,162 | $-10,890 | $-63,532 | $-57,179 | $-36,201 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,295 | 12,226 | -37,939 | -54,491 | -34,661 |
| Capital Expenditure | -483 | -382 | -2,184 | -1,435 | -991 |
| Free Cash Flow | -11,778 | 11,844 | -40,123 | -55,926 | -35,652 |